« Back
Home /
Camibirstat (FHD-286)

Camibirstat (FHD-286)

Item no.	DCC-DC60219-250mg
Manufacturer	DCChemicals
CASRN	2671128-05-3
Amount	250 mg
Quantity options	100 mg 10 mM x 1 ml in DMSO 1 g 250 mg
Category	Reagents & Chemicals Molecules
Type	Chemicals
Applications	FHD286(FHD 286 ) is a BRG1/BRM ATPase inhibitor for the treatment of BAF-related disorders such as acute myeloid leukemia.
Specific against	other
Smiles	[C@H]1(C)O[C@@H](C)CN(C2=NC(C3N=C(NC(=O)[C@@H](NC(=O)C4=CN(S(=O)(C)=O)C=C4)COC)SC=3)=CC=C2)C1
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Available
Manufacturer - Applications	FHD-286 is a selective, oral inhibitor of SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor. FHD-286 has the potential for the research of BAF (BRG1/BRM-associated factor)-related disorders such as acute myeloid leukemia.
Molecular Weight	562, 66

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 250 mg

available

Delivery expected until 11/13/2025

Express Delivery: Save 2 days

Compare

Add to wishlist

Get an offer